333 related articles for article (PubMed ID: 16534015)
1. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Urban P; Gershlick AH; Guagliumi G; Guyon P; Lotan C; Schofer J; Seth A; Sousa JE; Wijns W; Berge C; Deme M; Stoll HP;
Circulation; 2006 Mar; 113(11):1434-41. PubMed ID: 16534015
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.
Gao RL; Xu B; Lu SZ; Chen JL; Han YL; Chen JZ; Gai LY; Ge JB; Wang WM; Du ZM; Huo Y; Wang LF; Gao W; Chen JY; He B; Jia GL; Yang ZJ; Cao KJ; Li WM; Shen WF; Wan Z; Huang DJ; Zhu GY;
Int J Cardiol; 2008 Apr; 125(3):339-46. PubMed ID: 17434617
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry.
Bezerra H; Perin E; Berger P; Block P; Ramee S; Katz S; Kellet M; Dippel E; Schaer G; Britto S; Cohen S; Costa M
J Invasive Cardiol; 2010 Feb; 22(2):48-55. PubMed ID: 20124586
[TBL] [Abstract][Full Text] [Related]
4. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
[TBL] [Abstract][Full Text] [Related]
6. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
7. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
Ortolani P; Balducelli M; Marzaroli P; Piovaccari G; Menozzi A; Guiducci V; Sangiorgio P; Tarantino F; Geraci G; Castriota F; Tondi S; Saia F; Cooke RM; Guastaroba P; Grilli R; Marzocchi A; Maresta A
Circulation; 2008 Feb; 117(7):923-30. PubMed ID: 18250265
[TBL] [Abstract][Full Text] [Related]
8. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study.
Saia F; Lemos PA; Lee CH; Arampatzis CA; Hoye A; Degertekin M; Tanabe K; Sianos G; Smits PC; McFadden E; Hofma SH; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
Circulation; 2003 Oct; 108(16):1927-9. PubMed ID: 14557354
[TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE (Tuscany Registry of sirolimus for unselected in-stent restenosis) registry at 4 years.
Liistro F; Fineschi M; Grotti S; Angioli P; Carrera A; Ducci K; Gori T; Falsini G; Pierli C; Bolognese L
J Am Coll Cardiol; 2010 Feb; 55(7):613-6. PubMed ID: 20170784
[TBL] [Abstract][Full Text] [Related]
11. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
Kelbaek H; Kløvgaard L; Helqvist S; Lassen JF; Krusell LR; Engstrøm T; Bøtker HE; Jørgensen E; Saunamäki K; Aljabbari S; Thayssen P; Galløe A; Jensen GV; Thuesen L
J Am Coll Cardiol; 2008 May; 51(21):2011-6. PubMed ID: 18498953
[TBL] [Abstract][Full Text] [Related]
13. Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry.
Daemen J; Kukreja N; van Twisk PH; Onuma Y; de Jaegere PP; van Domburg R; Serruys PW
Am J Cardiol; 2008 Apr; 101(8):1105-11. PubMed ID: 18394442
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of sirolimus-eluting stents in diabetics with complex coronary lesions].
Berenguer A; Mainar V; Bordes P; Valencia J; Gómez S
Rev Esp Cardiol; 2006 Feb; 59(2):117-24. PubMed ID: 16540032
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
[TBL] [Abstract][Full Text] [Related]
16. Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry).
Zahn R; Hamm CW; Schneider S; Zeymer U; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Sabin G; Senges J;
Am J Cardiol; 2005 Jun; 95(11):1302-8. PubMed ID: 15904633
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
Daemen J; Tanimoto S; García-García HM; Kukreja N; van de Sande M; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW
Am J Cardiol; 2007 Apr; 99(8):1027-32. PubMed ID: 17437722
[TBL] [Abstract][Full Text] [Related]
19. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
